Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000005

Director acquired 1,725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Anderson Kenneth Carl Director 2024-01-02 Grant or award +1,725 $6.52 $11,247 110,962 D
Loading xslF345X05/wk-form4_1704316284.xml…